Please login to the form below

Not currently logged in
Email:
Password:

Senior pharma appointments at Sanofi

Sanofi has appointed GSK senior vice president, Anne C Whitaker, as president, North America Pharmaceuticals, while CEO of Sanofi's US operations, Greg Irace, is to become senior vice president, Global Services

Greg Irace - Sanofi
Greg Irace

Sanofi has appointed GlaxoSmithKline (GSK) senior vice president, Anne C Whitaker, as president, North America Pharmaceuticals, while CEO of Sanofi's US operations, Greg Irace, is to become senior vice president, Global Services.

Whitaker has been senior vice president and business unit head, Cardiovascular, Metabolic and Urology, at GSK since 2009 after joining the company in 1992. She will begin her role with Sanofi on September 1, 2011, and will report to Hanspeter Spek, president, Global Operations.

Her responsibilities will include driving growth of Sanofi's pharmaceutical operation in the US, the company having seeing a decline in sales of 4.1 per cent in the region for the first quarter of 2011. Whitaker will also become a member of the global management committee.

Irace has been at Sanofi since 1994, taking over his current US responsibilities in 2007. In his newly created role, he will be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared information services.

He will report to Jérôme Contamine, executive vice president and chief financial officer, Sanofi.

25th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics